D.C. Mun. Regs. r. 22-A3419

Current through Register Vol. 71, No. 24, June 14, 2024

Rule 22-A3419 - MEDICATION/SOMATIC TREATMENT

3419.1

Medication/Somatic Treatment services are medical services and interventions, including physical examinations; prescription, supervision, or administration of mental- health related medications; monitoring and interpreting results of laboratory diagnostic procedures related to mental health-related medications; and medical interventions needed for effective mental health treatment provided as either an individual or group intervention.

3419.2

Medication/Somatic Treatment services include monitoring the side effects and interactions of a consumer's medications and the adverse reactions which a consumer may experience and providing restorative information and direction for symptom and medication self-management.

3419.3

Group Medication/Somatic Treatment services shall be therapeutic, educational, and interactive with a strong emphasis on group member selection. These services shall facilitate therapeutic peer interaction and support as specified in the Plan of Care.

3419.4

Each Medication/Somatic Treatment provider shall offer:

(a) A comprehensive psycho-educational program for consumers and families, as appropriate, regarding the consumer's mental illness, emotional disturbance, or behavior disorder; treatment and recovery goals; potential benefits and risk of treatment; and self- monitoring aids; and

(b) Consumer/family groups for restorative information, support, and enhancement of the therapeutic alliance between the consumer and the MHRS provider.

3419.5

Consumers receiving Medication/Somatic Treatment shall participate in a psychoeducational session to discuss medication side effects, adverse reactions to medications, and medication self- monitoring and management.

3419.6

Medication/Somatic Treatment shall be provided with no annual limits on services.

3419.7

Medication/Somatic Treatment shall not be billed on the same day as:

(a) ACT; or

(b) IDT.

3419.8

Medication/Somatic Treatment shall be provided:

(a) At the MHRS provider's service site;

(b) By telemedicine pursuant to 29 DCMR § 910;

(c) In natural settings, including the consumer's home or community setting; or

(d) A residential facility of sixteen (16) beds or less unless otherwise stated by the Department.

3419.9

The following are considered qualified practitioners of Medication/Somatic Treatment:

(a) Psychiatrists;

(b) APRNs;

(c) PAs;

(d) RNs; and

(e) Licensed Practical Nurses.

D.C. Mun. Regs. r. 22-A3419

Final Rulemaking published at 48 DCR 10297 (November 9, 2001); as amended by Final Rulemaking published at 51 DCR 9308 (October 1, 2004); as amended by Final Rulemaking published at 52 DCR 5682 (June 17, 2005); amended by Final Rulemaking published at 67 DCR 10674 (9/4/2020); amended by Final Rulemaking published at 68 DCR 012400 (11/26/2021); amended by Final Rulemaking published at 70 DCR 3050 (3/10/2023), effective date corrected to 4/7/2023, by Errata Notice published at 71 DCR 4474 (4/19/2024).